Live Breaking News & Updates on Pompeii Phase

Stay updated with breaking news from Pompeii phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript February 28, 2024 Amicus Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics’ Full Year 2023 Financial Results Conference […] ....

United Kingdom , San Diego , United States , Bradley Campbell , Jeff Castelli , Simon Harford , Jeff Gatseli , Asia Pacific , Middle East , Pompe Disease , Chief Development Officer , Amicus Pompe , Annual World Symposium , Treatment Award , Chief Financial Officer , Pompeii Phase , Thanks Simon , Buy According , Future Stocks For The Long , Amicus Therapeutics , Bradley Campbell , Rare Disease , Chief Executive Officer , Jeff Castelli , Chief Medical Officer , Andrew Faughnan ,

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics Full Year 2023 Financial Results Conference Call and Webcast. ....

United States , United Kingdom , San Diego , Jeff Gatseli , Salveen Richter , Asia Pacific , Simon Harford , Bradley Campbell , Andrew Faughnan , Morgan Stanley , Anupam Rama , Ellen Rosenberg , Malcolm Kuno , Eliana Merle , Mitchell Goldman , Ellie Merle , Jeff Castelli , Joseph Schwartz , Sebastien Martel , Kristen Kluska , Goldman Sachs , Cantor Fitzgerald , Clinical Trial Program , Exchange Commission , Development Officer , Amicus Therapeutics Inc ,